Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00674856 · ClinicalTrials.gov registry record · Phase 1
A Pharmacokinetics and Safety Study of Naproxcinod in Subjects With Impaired Renal Function
A Phase 1 study, sponsored by NicOx.
- Completed
- Registry status
- Phase 1
- Development phase
- 32
- Enrollment target
NCT00674856 is a Phase 1 study that has completed, run by NicOx. The registered enrollment target is 32 participants.
The verdict
NCT00674856, a Phase 1 study, has completed, sponsored by NicOx.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 32 participants
- Enrollment target
Study Summary
To study the pharmacokinetics and safety of naproxcinod in patients with impaired renal function
Interventions
- DRUG naproxcinod
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2008-05 |
| Est. Completion | 2008-10 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00674856
The ClinicalTrials.gov registry entry for NCT00674856 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NicOx, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which naproxcinod is the first listed.
NCT00674856 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00674856 about?
NCT00674856 is a clinical study titled "A Pharmacokinetics and Safety Study of Naproxcinod in Subjects With Impaired Renal Function". To study the pharmacokinetics and safety of naproxcinod in patients with impaired renal function
What is the current status of trial NCT00674856?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 32 participants. The study started on 2008-05. Estimated completion is 2008-10.
What interventions are being tested in trial NCT00674856?
The interventions under investigation include: naproxcinod (DRUG).
Who is sponsoring clinical trial NCT00674856?
This trial is sponsored by NicOx, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.